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Background: Nested PCR is a commonly used technique in diagnosis of malaria owing to its high sensitivity and
specificity. However, it is time-consuming, open to considerable risk of contamination and has low cost-efficiency.
Using amplification targets presented in multiple copies, such as rRNA 18S, or mitochondrial targets with an even
higher copy number, might increase sensitivity.
Methods: The sensitivity and specificity of two newly designed Plasmodium genus-specific single-round
amplification PCR programmes, based on previously published primers targeting 18S and mitochondrial genome,
were compared with a widely used nested 18S PCR. Analyses of dilution series from Plasmodium falciparum
reference material were performed, as well as retrospective analyses of 135 blood samples, evaluated by routine
microscopy, from 132 fever patients with potential imported malaria. Sequencing of the 220 bp mitochondrial PCR
products was performed.
Results: At the threshold dilution 0.5 parasites/μl, the sensitivity of the mitochondrial PCR was 97% (29/30 parallels),
that of the single-round 18S PCR 93% and the reference nested 18S PCR 87%. All three assays detected as low as
0.05 p/μl, though not consistently. In the patient cohort, malaria was diagnosed in 21% (28/135) samples, defined
as positive by at least two methods. Both single-round amplification assays identified all malaria positives diagnosed
by nested PCR that had sensitivity of 96% (27/28). The mitochondrial PCR detected one additional sample, also
positive by microscopy, and was the only method with 100% sensitivity (28/28). The sensitivity and specificity of the
mitochondrial PCR were statistically non-inferior to that of the reference nested PCR. Microscopy missed two
infections detected by all PCR assays. Sequencing of the genus-specific mitochondrial PCR products revealed
different single nucleotide polymorphisms which allowed species identification of the 28 sequences with following
distribution; 20 P. falciparum, six Plasmodium vivax, one Plasmodium ovale and one Plasmodium malariae.
Conclusions: In this study, design of PCR programmes with suitable parameters and optimization resulted in
simpler and faster single-round amplification assays. Both sensitivity and specificity of the novel mitochondrial PCR
was 100% and proved non-inferior to that of the reference nested PCR. Sequencing of genus-specific mitochondrial
PCR products could be used for species determination.
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More than three billion people world-wide are exposed
to malaria, resulting in an estimated 200 million malaria
cases and 1.2 million deaths in 2010 [1]. Routine diagno-
sis is usually done by microscopy and/or rapid diagnostic
antigen detection tests, and may be influenced by factors
such as the technologists’ level of experience, and equip-
ment quality [2,3]. Several molecular techniques have
been developed, including polymerase chain reaction
(PCR), with the aim of increasing the sensitivity and
specificity [4,5].
Malaria PCR was first introduced in 1990 [6], and sub-
sequently has evolved with new amplification methods
such as Real-Time PCR and loop-mediated isothermal
amplification (LAMP) [7,8]. Both the latter methods
have advantages over conventional PCR in turnaround
time and in practical use as the detection step is incor-
porated into the amplification step. Nevertheless, the
nested PCR originally described by Snounou et al. in
1993 [9] and improved in 1999 [10], remains commonly
used and often regarded as a gold standard/reference
method. Nested PCR exhibits high sensitivity and specifi-
city due to two amplification steps, but is time-consuming,
open to considerable risk of contamination and has low
cost-efficiency [11-16].
High sensitivity has also been achieved by using
amplification targets existing in multiple copies in the
Plasmodium genome [17]. A common target is the con-
served small subunit ribosomal RNA 18S locus [9,18,19]
which in the Plasmodium falciparum chromosomal gen-
ome exists in five to eight copies depending on the
strain [20]. Snounou et al. [9] reported a sensitivity of
one to 10 parasites per microlitre (p/μl) of blood using
nested PCR with 18S as the target gene. Polley et al. [21]
reported a sensitivity of 5 p/μl introducing a LAMP
method using an amplification target on the 6 kb mito-
chondrial genome. In comparison, a LAMP assay employ-
ing primers targeting 18S had a sensitivity limited to
approximately 100 copies of the gene for P. falciparum
[19]. Early ring stage P. falciparum parasites typically have
one mitochondrial organelle, which contains about 20
copies of the 6 kb genome, while mature gametocytes have
as much as four to eight mitochondrial organelles [22,23].
Although one would expect assays using mitochondrial
targets to show higher sensitivity given the higher copy
number, PCR-based methods targeting 18S are commonly
the methods of choice [17,24].
The main aim of this study was to design practical
single-round amplification Plasmodium genus-specific
PCR assays, based on previously described primers tar-
geting the 18S locus [9] and the mitochondrial genome
[21], with sensitivity and specificity non-inferior to
nested PCR [10]. Comparisons were performed using
reference material and samples from a cohort of feverpatients with potential imported malaria in Bergen,
Norway.
Methods
Patient materials, positive controls and reference sample
The patient material used in this study had been col-
lected between 2006 and 2011 at Haukeland University
Hospital, Bergen, Norway. It included 135 whole blood
samples from a cohort of 132 fever patients with poten-
tial imported primary or recurrent malaria. As part of
the routine work-up these samples had been previously
analysed for malaria parasites on Giemsa-stained, thin
and thick slides by experienced microscopists. The rou-
tine microscopy results and clinical information were
collected retrospectively from patient files.
External DNA controls extracted from P. falciparum,
Plasmodium vivax, Plasmodium ovale and Plasmodium
malariae supplied by the Centre for Tropical Diseases,
McGill University (Quebec, Canada) [25] were used in
the validation of the genus-/ and species-specific PCR
assays in the study. In addition, an external reference
sample of P. falciparum, US 04 F Nigeria XII (World
Health Organization, Geneva, Switzerland), was used to
examine the sensitivity of the genus-specific PCR assays.
P. falciparum was the only cultivated species accessible.
The reference material contained exclusively ring stage
parasites in a concentration of 200 p/μl. Employing tem-
plate from the reference material together with extracted
DNA from blood of a Norwegian malaria negative vol-
unteer, a combination of two 10-folds dilutions series
were prepared giving the following series: 10 p/μl, 5 p/
μl, 1 p/μl, 0.5 p/μl, 0.1 p/μl, 0.05 p/μl, and 0.001 p/μl.
From all blood samples DNA was extracted using
QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. Both blood
and extracted DNA material was stored at -20°C prior to
application.
PCR methods
Three PCR assays, two genus-specific and one species-
specific, were assessed in the cohort of patient samples
described above. The genus-/ and species-specific nested
18S PCR as described by Singh et al. [10] was included
as a reference method. In each PCR assay the reaction
mixtures contained 2 μl of DNA template and 12.5 μl
2X HotStarTaq Master Mix (Qiagen) at a total volume
of 25 μl. The amplifications were performed by using
GeneAmp PCR System 9700 (Applied Biosystems,
Carlsbad, CA, USA), and the PCR products were ana-
lysed by electrophoresis using 2% SeaKemW agarose gel
(Lonza, Rockland, ME, USA) with 1X GelRed™ (Biotium,
Hayward, CA, USA). Concentrations of primers and
additional MgCl2 were optimized for each assay examined
as described below.
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6 and rPLU 5 (Table 1) targeting 18S. The amplification
conditions were modified and optimized from the original
nested [9] to a single-round amplification assay with cycle
parameters as follows: step 1, 95°C for 15 min; step 2, de-
naturation at 95°C for 10 sec; step 3, annealing at 63°C for
10 sec; step 4, extension at 72°C for 75 sec; steps 2-4
repeated 50 times; and step 5, 72°C for 10 min.
The other genus-specific assay was a new single-round
amplification PCR using primers PgMt19 F3 and
PgMt19 B3 (Table 1), targeting the mitochondrial gen-
ome and previously employed in a LAMP assay [21].
The primers were analysed using Oligo v6 primer ana-
lysis software (Molecular Biology Insights, Cascade, CO,
USA), and tested with Basic Local Alignment Search
Tool (BLAST, National Center for Biotechnology Infor-
mation, Bethesda, MD, USA) before being considered
suitable for use in a conventional PCR assay. Subse-
quently, the following amplification conditions were
designed: step 1, 95°C for 15 min; step 2, denaturation at
95°C for 10 sec; step 3, annealing at 62°C for 10 sec; step
4, extension at 72°C for 15 sec; steps 2-4 repeated 50
times; and step 5, 72°C for 10 min. Reaction mixture for
both assays contained 250 nM of each primer, and add-
itionally 4 mM MgCl2 (New England BioLabs, Ipswich,
MA, USA).
The P. falciparum, P. vivax, P. ovale and P. malariae
species-specific PCR protocol was employed on all genus-
specific PCR positive samples applying primers targeting
18S previously published by Padley et al. [26]. As opposed
to the original multiplex assay, each sample was analyzed
in four separate reaction mixtures to avoid difficulties in
species interpretation due to similar product sizes. Only a
few single nucleotide polymorphisms (SNPs) distinguish
the different forward primers’ hybridization sites. In order
to avoid non-specific cross-binding between P. falciparum
and P. vivax samples, a new P. vivax forward primer
(Table 1) was designed using Oligo v6, the sequence align-
ment editor software BioEdit v7 (Tom Hall, Carlsbad, CA,Table 1 Primers applied for the amplifications and sequencin
Primer1 Sequence
rPLU 6 forward 50-tta aaa t
rPLU 5 reverse 50-cct gtt g
PgMt19 F3 forward 50-tcg ctt c
PgMt19 B3 reverse 50-aat tga t
Plasmodium falciparum forward 50-aac aga
Plasmodium vivax forward 50-gag cgt
Plasmodium ovale forward 50-ctg ttc t
Plasmodium malariae forward 50-cgt taa g
Species-specific reverse 50-gta tct g
1 The primers were obtained from Eurogentec (Seraing, Belgium).USA) and BLAST. The amplification conditions were
modified and amplification time substantially reduced
from six to two hours. The new cycling parameters were:
step 1, 95°C for 15 min; step 2, denaturation at 95°C for
10 sec; step 3, annealing at 65°C for 10 sec; step 4, exten-
sion at 72°C for 30 sec; steps 2-4 repeated 45 times; and
step 5, 72°C for 10 min. The reaction mixtures contained
additional MgCl2 which was optimized as follows: 4 mM
for P. ovale, 2 mM for P. falciparum and P. malariae, and
1 mM for P. vivax. The primer concentrations were 250
nM with an exception of 150 nM for P. ovale.Sequencing
For quality assurance purposes, all PCR products from
genus-specific positive samples using primers PgMt19
F3&B3 (Table 1) were sequenced in both directions. The
PCR products were purified with ExoSAP-ITW (USB
Corporation, Cleveland, OH, USA) according to the
manufacturer’s instructions, prior to the following cycle
conditions being applied using GeneAmp PCR System
9700 (Applied Biosystems): step 1, 96°C for 10 sec; step
2, 62°C for 5 sec; step 3, 60°C for 4 min; steps 1-3
repeated 27 times. Each reaction mixture contained 1 μl
BigDye v1.1 (Applied Biosystems), 2 μl sequencing buffer
5X (Applied Biosystems), 0.5 μM primer, and 1 μl tem-
plate at a total volume of 10 μl. The sequences were
obtained with the ABI PRISMW 3730 DNA Analyzer
(Applied Biosystems). BioEdit v7 was used prior to se-
quence identification using BLAST.Statistical methods
Proportions were compared applying prtest command
using Stata 11 (Stata Corp, College Station, Texas, USA),
and differences in sensitivity and specificity with 95%
confidence intervals (95% CI) were calculated. Non-
inferior of the test was considered proved if the upper
boundary of the 95% CI of the sensitivity difference was
less than a predefined delta of 5%.g examined in this study
Published by
tg cag tta aaa cg Snounou et al. [9]
tt gcc tta aac ttc Snounou et al. [9]
ta acg gtg aac Polley et al. [21]
ag tat cag cta tcc ata g Polley et al. [21]
cgg gta gtc atg att gag Padley et al. [26]
tca aag caa aca ga This study
tt gca ttc ctt atg c Padley et al. [26]
aa taa acg cca agc g Padley et al. [26]
at cgt ctt cac tcc c Padley et al. [26]
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Results
The sensitivity of detection was examined for the three
genus-specific amplification assays; the new single-round
amplification mitochondrial PCR employing primers
PgMt19 F3&B3 [21], the modified single-round amplifi-
cation 18S PCR employing primers rPLU 6&5 [9], and
nested 18S PCR [10] as the reference method. Based on
30 parallels of the described dilution series, the 0.5 p/μl
dilution proved to be the threshold detection level for all
three assays (Figure 1). The mitochondrial PCR detected
0.5 p/μl with 97% sensitivity (29/30), while the modified
18S PCR and nested 18S PCR detected 0.5 p/μl with
93% (28/30) and 87% (26/30) sensitivity, respectively. At
the threshold detection level of 0.5 p/μl, the sensitivity
of the mitochondrial PCR, was statistically non-inferior
to that of the reference nested 18S PCR, as the upper
boundary of the 95% CI (-23.8% to 3.8%) of the sensitiv-
ity difference (10.0%) was less than the predefined delta
of 5%. Although, the sensitivity of the modified 18S PCR
also was higher than that of the reference nested 18S
PCR in absolute numbers, statistical non-inferiority
could not be proved in this sample size (sensitivity dif-
ference -6.7%, 95% CI -21.8% to 8.4%). All three assays
detected positive DNA as low as 0.05 p/μl, though not
consistently so by any method.
After having determined sensitivity of detection in
standardized material, the 135 patient samples (132
patients) were screened for the presence of malaria by
the three genus-specific PCR assays. Among these sam-
ples, 21% (28/135) were defined as malaria positive by at
least two of the methods among microscopy and the
three different genus-specific PCR assays. The new mito-
chondrial PCR was 100% sensitive detecting all 28 posi-
tives. Both the modified 18S PCR and the nested 18SFigure 1 Sensitivity of three different Plasmodium genus PCR protoco
stock of Plasmodium falciparum, US 04 F Nigeria XII. The 2% agarose gel pi
amplification mitochondrial PCR employing primers PgMt19 F3 & B3 [21] (A
rPLU 6 & 5 [9] (B), and gold standard genus-specific nested 18S PCR [10] (C
respectively. Lane 1 = 100 bp DNA Ladder (New England BioLabs), lane 2 =
8 = 0.001 p/μl, and 9 = no template. The new mitochondrial PCR had more
18S PCR.PCR detected 27 of the positives corresponding to a sen-
sitivity of 96%. Routine microscopy detected 26 of the
positives corresponding to a sensitivity of 93% (Table 2).
The mitochondrial PCR detected one positive sample
not detected by any of the two 18S PCR assays, which
was also positive by microscopy. Two positive samples
not detected by microscopy were detected by all three
PCR assays (Table 2). The sensitivity of the mitochon-
drial PCR was statistically non-inferior to that of the
reference 18S PCR, as the upper boundary of the 95% CI
(-10.4% to 3.3%) of the sensitivity difference (-3.6%) was
less than the predefined delta of 5%. Although the sensi-
tivity of the modified 18S PCR was equal to that of the
reference nested 18S PCR in absolute numbers, statis-
tical non-inferiority could not be proved in this patient
cohort (sensitivity difference 0%, 95% CI -9.7% to 9.7%).
None of the malaria-negative patients had false posi-
tive tests by any of the diagnostic methods, thus all the
tests had 100% specificity in this cohort. The specificity
of both the mitochondrial PCR and the modified 18S
PCR were statistically non-inferior to that of the refer-
ence nested 18S PCR (specificity difference 0.0%, 95% CI
0.0 to 0.0%).
The 28 malaria positive samples were all further exam-
ined by two species-specific 18S amplification assays; an
assay modified from a multiplex PCR [26], and species-
specific nested PCR assay [10] as the reference method.
The first assay, which was modified from a multiplex
into four separate reactions with a new P. vivax forward
primer, as described above, showed no cross-bindings
between the new P. vivax primer and P. falciparum posi-
tive samples (Figure 2). Previously observations showed
that the original P. vivax forward primer unspecifically
cross-bonded with P. falciparum positive samples, espe-
cially when the parasitaemia was high.
Sequencing of the genus-specific mitochondrial PCR
products was performed giving high-quality sequences
of full length. When the sequences were run throughls. A dilution series, run in 30 parallels, was prepared from a 200 p/μl
cture shows a typical parallel for each assay; new single-round
), modified single-round amplification 18S PCR employing primers
). The product sizes are 220 base pair (bp), 1200 bp, and 250 bp,
10 p/μl, 3 = 5 p/μl, 4 = 1 p/μl, 5 = 0.5 p/μl, 6 = 0.1 p/μl, 7 = 0.05 p/μl,
defined bands than the modified 18S PCR, and especially the nested
Table 2 Genus-specific results from a cohort of 132 fever patients with potential imported malaria
Samples (n = 135) New single-round amplification
mitochondrial (PCRPgMt19 F3 & B3 [21])
Modified single-round amplification




Positive 28 27 27 26
Negative 107 108 108 109
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insert/deletion which allowed species determination in
all the 28 sequences, revealing 20 P. falciparum, six
P. vivax, one P. ovale, and one P. malariae sequences
(Figure 3, Table 3). Both species-specific 18S PCR assays
identified 18 P. falciparum, six P. vivax, one P. ovale,
and one P. malariae single infections, and one double in-
fection of P. falciparum and P. malariae (Table 3). While
the routine microscopy had identified 20 P. falciparum,
three P.m vivax, and one Plasmodium knowlesi/inconclu-
sive single infections, and two samples with P. falciparum
in double infection with P. ovale and P. vivax, respectively
(Table 3).
In seven samples (six patients) the different methods
had discordant results (Table 4). Based on the combined
results from routine microscopy, all PCR assays and
sequencing, these samples were evaluated giving the
following interpretations; sequencing as a diagnostic
method missed Plasmodium malariae in a double infec-
tion of P. falciparum and P. malariae, all 18S PCR assays
(genus-/and species-specific) missed one P. falciparum
positive sample detected by both the new mitochondrial
PCR and microscopy, and routine microscopy missed one
P. malariae and one P. vivax single infection as well asFigure 2 No cross-binding reactions applying new Plasmodium
vivax forward primer in modified species-specific 18S PCR [26].
The original Plasmodium vivax primer from a multiplex PCR [26]
cross-bonded with Plasmodium falciparum when applied in the
modified species-specific 18S PCR [26]. The new Plasmodium vivax
(Pv) primer was cross tested against different Plasmodium falciparum
(Pf) patient samples with diverse levels of high parasitaemia. The
results showed on a 2% agarose gel. Lane 1 = 100 bp DNA Ladder,
lanes 2-6 = Five different positive Pv patient samples, lane 7 = 2% Pf,
lane 8 = 2-3% Pf, lane 9 = 7% Pf, lane 10 = 7-10% Pf, lane 11 = 10-
15% Pf, lane 12 = 20% Pf, and lane 13 = No template. The product
size of Pv is 241 bp.P. malariae in a double infection of P. falciparum and P.
malariae. Microscopy incorrectly evaluated two single
infections as double infections with P. falciparum, and in-
correctly evaluated a P. vivax as P. knowlesi infection
(Table 4).
Discussion
The two Plasmodium genus-specific single-round ampli-
fication PCR assays presented in this study were as
follows: a new mitochondrial PCR employing primers
PgMt19 F3&B3 [21], and a modified 18S PCR employing
primers rPLU 6&5 [9]. By designing single-round ampli-
fication assays, the cost-efficiency, turnaround time, con-
tamination risk, and the possibility of technical errors
are considerably reduced compared with the nested PCR
reference method [10]. Previously published 18S pri-
mers, rPLU3&4 [10], were also considered for single-
round amplification because of short product size
(250 bp versus 1200 bp), but discarded due to high
annealing temperatures, 71 and 75°C (contra 63 and
64°C for rPLU6&5). Snounou and Singh [9,10] reported
that the 18S primers showed reduced sensitivity in
single-round PCR amplifications, however this study
shows that single-round amplifications have the same
sensitivity and specificity as nested PCR given suitable
parameters and optimisation. The new PCR programs
were designed with a high number of cycles and high
concentration of additional magnesium chloride, so that
the sensitivity of nested PCR was maintained. Further-
more, due to the quick cycles in the designed programs
and the high annealing temperatures, also the specificity
of nested PCR was maintained despite the high number
of cycles. The results from the dilution series showed
that both the single-round amplification assays detected
a higher number of parallels with positive DNA at the
threshold dilution level of 0.5 p/μl compared to the
nested PCR reference method. In the patient material
the two single-round assays correctly identified all the
positives and negatives found by the nested PCR, with
the exception of one sample positive only by mitochon-
drial PCR and microscopy. Statistically the sensitivity of
the mitochondrial PCR was non-inferior to that of the
reference nested 18S PCR in this patient cohort as well
as in the dilution series (at the threshold 0.5p/ μl dilu-
tion). Although the sensitivity of the modified 18S PCR
could not be proven to be statistically non-inferior to
nested PCR in this limited sample size, the test was
Figure 3 Sequencing of Plasmodium genus-specific mitochondrial PCR products reveals polymorphisms consequently identifying
malaria species. Sequencing of the genus-specific mitochondrial PCR products, employing primers PgMt19 F3&B3 [21], gave high-quality
sequences of full length. Run through BLAST the results showed that the four species were distinguished by two to six single nucleotide
polymorphisms and one insert/deletion consequently allowing sequencing to be used as an alternative species-specific determination method in
our cohort.
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bers. The specificities of both single-round amplification
assays were statistically non-inferior to that of the nested
PCR.
In Plasmodium parasites the mitochondrial genome is
presented in a higher copy number than 18S, especially
in gametocytes. While the copy number of 18S locus
varies depending on strains, and not on the stages of the

















18 Pf Pf Pf Pf
1 Pf Pf + Pm Pf + Pm Pf
1 Pf Negative Negative Pf
3 Pv Pv Pv Pv
1 Pv Pv Pv Negative
1 Pv Pv Pv Pf + Pv
1 Pv Pv1 Pv1 Pk2
1 Po Po Po Pf + Po
1 Pm Pm Pm Negative
Abbreviations: Pf, Plasmodium falciparum; Pv, Plasmodium vivax; Po,
Plasmodium ovale; Pm, Plasmodium malariae; Pk, Plasmodium knowlesi.
1 Plasmodium knowlesi primers were not included in the assay.
2 Evaluated as inconclusive species by microscopy, but with emphasis on
possible Plasmodium knowlesi infection.[20], the multiple mitochondrial genome is located in
the mitochondrial organelles which can varies in number
through the different parasite’s stages [22,23]. The results
from the dilution series, containing ring stage parasites ex-
clusively, showed the same threshold detection level for all
three genus-specific PCR assays, though the mitochon-
drial PCR had highest sensitivity on this detection level. In
ring stage parasites the copy number of the mitochondrial
genome is approximately three to four times higher than
the copy number of the 18S locus. Compared to 18S PCR,
the mitochondrial PCR detected one more sample
among the patient material, and notably none of the four
18S PCR assays (two genus-/ and two species-specific)
detected this sample. The patient had recrudescence fol-
lowing primary P. falciparum infection two weeks earlier.
Maturation of P. falciparum gametocytes takes eight to
10 days [27,28]. Although microscopy detected one single
ring stage parasite, the difference in sensitivity in this sam-
ple is possibly due to submicroscopic gametocytaemia; the
copy number of the mitochondrial genome in a gameto-
cyte is approximately 10 to 32 times higher than the copy
number of the 18S locus.
Due to short product size, 220 bp, the amplification
time with the new mitochondrial PCR programme takes
one-and-a-half hours less than the modified 18S PCR
programme, and three hours less than nested 18S PCR
[10]. Another advantage of the short product size, was
that the mitochondrial PCR products could be easily
full-length sequenced. As an alternative to species-
specific PCR, the SNPs found in the sequences allowed
Table 4 Seven samples (six patients) with discordant results between the different methods












P 1 Negative 01 Pm Pm Primary Ghana Pm overlooked by microscopy
P 2 Negative2 01 Pv Pv Primary New
Guinea
Pv overlooked by microscopy




Inconclusive/ incorrect diagnosis by
microscopy
P 3 Pf + Po <1% Po Po Recurrent
(Relapse)
Uganda Over-diagnosed mixed infection by
microscopy
P 4 Pf <1% Pf + Pm Pf Primary Liberia Under-diagnosed mixed infection by
microscopy/sequencing
P 5 Pf + Pv 1% Pv Pv Primary3 SEA or CA Over-diagnosed mixed infection by
microscopy
P 6 Pf 4 <1% Negative Pf Recurrent
(Recrudescence)
Guinea Un-detected low Pf parasitaemia by
18S PCR
Abbreviations: Pf, Plasmodium falciparum; Pv, Plasmodium vivax; Po, Plasmodium ovale; Pm, Plasmodium malariae; Pk, Plasmodium knowlesi; SEA, South east Asia;
CA, Central America.
1 Not detected any parasites.
2 Positive microscopy two days later (1% parasitaemia) and then the patient was diagnosed with severe malaria and treatment initiated.
3 Not given hypnozoite-eradicating treatment and re-admitted four weeks later with relapse of Plasmodium vivax.
4 Only one parasite detected.
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the validity of the SNPs warrants further investigation to
evaluate if the SNPs are universal in different strains of
the species. All of the 28 sequences correctly identified
species compared to the species confirmed by either the
species-specific 18S PCR assays or microscopy. However,
sequencing only identified P. falciparum species in a
double infection with P. malariae, which was detected
by both the species-specific 18S PCR assays. This can be
explained by P. falciparum predominance due to its
ability to induce high parasitaemia. Despite missing the
less numerous species in mixed infections, sequencing of
the mitochondrial PCR products can be useful in species
diagnosis. Compared to a species-specific multiplex PCR,
the sequencing method avoids unwanted cross-bindings
due to similar primers’ hybridization sites, difficulties in
interpreting results due to similar product sizes, and lower
sensitivity due to competing primers. Due to high quality
sequences this method only requires one reaction for
every positive sample to perform species determination,
compared to four/five in non-multiplex species-specific
PCR assays. Sequencing of positive mitochondrial PCR
products also allows for identification of species where
species-specific 18S PCR assays may fail to detect low
parasitaemia, as shown in the sample with recrudescence
in this patient cohort. The simple and rapid mitochondrial
PCR assay, with the advantages of high sensitivity and that
species-specific sequencing is possible in positive samples,
might therefore have a value in screening purposes, espe-
cially in large scale epidemiologic and surveillance studies
as well as in diagnostics.Conclusions
In this study two simple and rapid single-round amplifi-
cation assays for detection of malaria were described.
The novel mitochondrial PCR was the only method with
100% sensitivity in this patient cohort, and both its sen-
sitivity and specificity was statistically non-inferior to
that of the reference 18S nested PCR [10]. The method
may be of particular value in samples of low parasitaemia/
gametocytaemia and in large-scale studies. Sequencing of
the genus-specific mitochondrial PCR products or devel-
oping the assay to real-time PCR could be an alternative
to species-specific PCR in species determination.
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